IBER NYSE
Ibere Pharmaceuticals
1W: +0.1%
1M: +0.3%
3M: +2.2%
1Y: +5.6%
$10.18
Last traded 2023-03-01 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$13M
Net Income
+0.0% YoY
$-1M
Free Cash Flow
+0.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE10.1%
ROA9.6%
ROIC-1.7%
Valuation
P/E29.9
P/B0.9
EV/EBITDA-31.5
Leverage
Debt/Equity0.00
Current Ratio0.24
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z17.17
Beneish M0.00